Invasive aspergillosis in patients with acute leukemia: Update on morbidity and mortality SEIFEM-C report

被引：87

作者：

Pagano, Livio

Caira, Morena

Picardi, Marco

Candoni, Anna

Melillo, Lorella

Fianchi, Luana

Offidani, Massimo

Nosari, Annamaria

机构：

[1] Univ Cattolica S Cuore, Ist Ematol, I-00168 Rome, Italy

[2] Univ Naples Federico II, Div Ematol, Naples, Italy

[3] Univ Udine, Clin Ematol, I-33100 Udine, Italy

[4] Osped S Giovanni Rotondo, Div Ematol, San Giovanni Rotondo, Italy

[5] Univ Ancona, Clin Ematol, Ancona, Italy

[6] Osped Niguarda Ca Granda, Div Ematol, Milan, Italy

[7] Osped Niguarda Ca Granda, Ctr Trapianti Midollo, Milan, Italy

来源：

CLINICAL INFECTIOUS DISEASES | 2007年 / 44卷 / 11期

关键词：

D O I：

10.1086/517849

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1524 / 1525

页数：2

共 11 条

[1] Refractory aspergillus pneumonia in patients with acute leukemia - Successful therapy with combination caspofungin and liposomal amphotericin [J].

Aliff, TB ;

Maslak, PG ;

Jurcic, JG ;

Heaney, ML ;

Cathcart, KN ;

Sepkowitz, KA ;

Weiss, MA .

CANCER, 2003, 97 (04) :1025-1032

[2] Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies [J].

Candoni, A ;

Mestroni, R ;

Damiani, D ;

Tiribelli, M ;

Michelutti, A ;

Silvestri, F ;

Castelli, M ;

Viale, P ;

Fanin, R .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (03) :227-233

[3] Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial) [J].

Cornely, Oliver A. ;

Maertens, Johan ;

Bresnik, Mark ;

Ebrahimi, Ramin ;

Ullmann, Andrew J. ;

Bouza, Emilio ;

Heussel, Claus Peter ;

Lortholary, Olivier ;

Rieger, Christina ;

Boehme, Angelika ;

Aoun, Mickael ;

Horst, Heinz-August ;

Thiebaut, Anne ;

Ruhnke, Markus ;

Reichert, Dietmar ;

Vianelli, Nicola ;

Krause, Stefan W. ;

Olavarria, Eduardo ;

Herbrecht, Raoul .

CLINICAL INFECTIOUS DISEASES, 2007, 44 (10) :1289-1297

[4] Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia [J].

Cornely, Oliver A. ;

Maertens, Johan ;

Winston, Drew J. ;

Perfect, John ;

Ullmann, Andrew J. ;

Walsh, Thomas J. ;

Helfgott, David ;

Holowiecki, Jerzy ;

Stockelberg, Dick ;

Goh, Yeow-Tee ;

Petrini, Mario ;

Hardalo, Cathy ;

Suresh, Ramachandran ;

Angulo-Gonzalez, David .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04) :348-359

[5] Consensus definitions for invasive fungal disease: Strengths, limitations, and revisions [J].

Donnelly, J. Peter .

MEDICAL MYCOLOGY, 2006, 44 :S285-S288

[6] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].

Herbrecht, R ;

Denning, DW ;

Patterson, TF ;

Bennett, JE ;

Greene, RE ;

Oestmann, JW ;

Kern, WV ;

Marr, KA ;

Ribaud, P ;

Lortholary, O ;

Sylvester, R ;

Rubin, RH ;

Wingard, JR ;

Stark, P ;

Durand, C ;

Caillot, D ;

Thiel, E ;

Chandrasekar, PH ;

Hodges, MR ;

Schlamm, HT ;

Troke, PF ;

de Pauw, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415

[7] Galactomannan and computed tomography - Based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study [J].

Maertens, J ;

Theunissen, K ;

Verhoef, G ;

Verschakelen, J ;

Lagrou, K ;

Verbeken, E ;

Wilmer, A ;

Verhaegen, J ;

Boogaerts, M ;

Van Eldere, J .

CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) :1242-1250

[8] Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy [J].

Maertens, J ;

Raad, I ;

Petrikkos, G ;

Boogaerts, M ;

Selleslag, D ;

Petersen, FB ;

Sable, CA ;

Kartsonis, NA ;

Ngai, A ;

Taylor, A ;

Patterson, TF ;

Denning, DW ;

Walsh, TJ .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (11) :1563-1571

[9]

Pagano L, 2001, HAEMATOLOGICA, V86, P862

[10]

Pagano L, 2006, HAEMATOLOGICA, V91, P1068

← 1 2 →